1. Home
  2. SRFM vs ANVS Comparison

SRFM vs ANVS Comparison

Compare SRFM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

HOLD

Current Price

$0.73

Market Cap

89.0M

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.81

Market Cap

76.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRFM
ANVS
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.0M
76.6M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
SRFM
ANVS
Price
$0.73
$1.81
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$3.25
$13.50
AVG Volume (30 Days)
1.9M
552.3K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
39.39
EPS
N/A
N/A
Revenue
$106,557,000.00
N/A
Revenue This Year
$25.90
N/A
Revenue Next Year
$20.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.54
52 Week High
$6.17
$5.50

Technical Indicators

Market Signals
Indicator
SRFM
ANVS
Relative Strength Index (RSI) 44.58 49.76
Support Level $0.66 $1.71
Resistance Level $0.86 $1.98
Average True Range (ATR) 0.06 0.09
MACD 0.00 -0.00
Stochastic Oscillator 27.81 35.29

Price Performance

Historical Comparison
SRFM
ANVS

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: